The RSM-scale: a pilot study on a new specific scale for self- and observer-rated quality of life in patients with schizophrenia

Riedel, Michael; Spellmann, Ilja; Schennach-Wolff, Rebecca; Obermeier, Michael; Musil, Richard

doi:10.1007/s11136-010-9744-z

Cited by 9 publications

(7 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Interviewer-assessment was also associated with larger correlations than self-assessment as reflected in Riedel et al . (2011).…”

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

“…The largest correlation coefficient ( r = 0.72) was between functioning assessed with GAF and ‘subjective wellbeing’ assessed by the interviewer with the Riedel-Spellmann-Musil-Scale (RSM-Scale) (Riedel et al ., 2011). The next four highest correlations were also assessed between these instruments ( r = 0.61 to 0.65) (Riedel et al ., 2011). The smallest significant correlation ( r = 0.10) was between functioning assessed with GAF and interviewer-assessed ‘mental and physical health’ of the QoLI brief, subjective items only (Reine et al ., 2005).…”

Section: Resultsmentioning

confidence: 99%

“…The most utilised QoL instrument was the WHOQOL-BREF, followed by the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36). Assessments of QoL were self-assessed, with four exceptions (Meijer et al ., 2002; Reine et al ., 2005; Riedel et al ., 2011; Rocca et al ., 2014).…”

Section: Resultsmentioning

confidence: 99%

See 3 more Smart Citations

Systematic review of global functioning and quality of life in people with psychotic disorders

Nevarez-Flores

Sanderson

Breslin

et al. 2018

Epidemiol Psychiatr Sci

View full text Add to dashboard Cite

AimsPeople with psychotic disorders face impairments in their global functioning and their quality of life (QoL). The relationship between the two outcomes has not been systematically investigated. Through a systematic review, we aim to explore the presence and extent of associations between global functioning and QoL and establish whether associations depend on the instruments employed.MethodsIn May 2016, ten electronic databases were searched using a two-phase process to identify articles in which associations between global functioning and QoL were assessed. Basic descriptive data and correlation coefficients between global functioning and QoL instruments were extracted, with the strength of the correlation assessed according to the specifications of Cohen 1988. Results were reported with reference to the Meta-analysis of Observational Studies in Epidemiology guidelines and PRISMA standards. A narrative synthesis was performed due to heterogeneity in methodological approaches.ResultsOf an initial 15 183 non-duplicate articles identified, 756 were deemed potentially relevant, with 40 studies encompassing 42 articles included. Fourteen instruments for measuring global functioning and 22 instruments for measuring QoL were used. Twenty-nine articles reported linear associations while 19 assessed QoL predictors. Correlations between overall scores varied in strength, primarily dependent on the QoL instrument employed, and whether QoL was objectively or subjectively assessed. Correlations observed for objective QoL measures were consistently larger than those observed for subjective measures, as were correlations for an interviewer than self-assessed QoL. When correlations were assessed by domains of QoL, the highest correlations were found for social domains of QoL, for which most correlations were moderate or higher. Global functioning consistently predicted overall QoL as did depressive and negative symptoms.ConclusionsThis review is the first to explore the extent of associations between global functioning and QoL in people with psychotic disorders. We consistently found a positive association between global functioning and QoL. The strength of the association was dependent on the QoL instrument employed. QoL domains strongly associated with global functioning were highlighted. The review illustrates the extensive array of instruments used for the assessment of QoL and to a lesser extent global functioning in people with psychotic disorders and provides a framework to understand the different findings reported in the literature. The findings can also inform the future choice of instruments by researchers and/or clinicians. The observed associations reassure that interventions for improving global functioning will have a positive impact on the QoL of people living with a psychotic disorder.

show abstract

“…Interviewer-assessment was also associated with larger correlations than self-assessment as reflected in Riedel et al . (2011).…”

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Systematic review of global functioning and quality of life in people with psychotic disorders

Nevarez-Flores

Sanderson

Breslin

et al. 2018

Epidemiol Psychiatr Sci

View full text Add to dashboard Cite

show abstract

“…Evaluation of effectiveness is broader than assessment of efficacy, and takes into account the effects of treatment on symptoms and potential side effects as well as the effects of treatment on a patient’s everyday functioning and well-being, family burden, and treatment adherence. 18 Real-world studies in schizophrenia have utilized several scales to assess improvements in QoL, including the Quality of Life Scale (QLS), 19 Short-Form Health Survey 36 (SF-36), 20 Tolerability and Quality of Life (TOOL), 21 Subjective Well-being (SWN) scale, 22 Riedel–Spellmann–Musil scale, 23 and World Health Organization Quality of Life Scale, Brief Version (WHOQOL-BREF). 24 …”

Section: Objectivementioning

confidence: 99%

Targets, attitudes, and goals of psychiatrists treating patients with schizophrenia: key outcome drivers, role of quality of life, and place of long-acting antipsychotics

Bartolomeis¹,

Fagiolini²,

Vaggi³

et al. 2016

NDT

View full text Add to dashboard Cite

PurposeThis survey of Italian psychiatrists was conducted to better define drivers of schizophrenia treatment choice in real-life practice, particularly for use of long-acting injectable (LAI) antipsychotics.MethodsBetween October 15 and December 15, 2014, 1,000 surveys were sent to psychiatrists who treat schizophrenic patients; 709 completed questionnaires were analyzed (71% response rate).ResultsThe two most important factors determining therapy success were efficacy (75% of responses) and tolerability (45%) followed by global functioning (24%) and quality of life (17%). LAI antipsychotics were most often used to facilitate regular treatment monitoring (49%), and 41% of psychiatrists thought that patients with low adherence who had failed oral therapy were well-suited for LAI antipsychotics. Only 4% of respondents saw LAI antipsychotics as appropriate for patients without other therapeutic options.ConclusionAlthough efficacy and tolerability were the most common factors used to evaluate treatment success in schizophrenia, psychiatrists also consider QoL and global functioning to be important.

show abstract

Discriminant Validity

Hubley

2023

Encyclopedia of Quality of Life and Well-Being Research

View full text Add to dashboard Cite

The RSM-scale: a pilot study on a new specific scale for self- and observer-rated quality of life in patients with schizophrenia

Abstract: The RSM-scale is a new scale to assess the quality of life in different dimensions of patients with schizophrenia treated with antipsychotics and shows good internal consistency, test-retest reliability, construct and discriminant validity.

Cited by 9 publications

References 36 publications

Systematic review of global functioning and quality of life in people with psychotic disorders

Systematic review of global functioning and quality of life in people with psychotic disorders

Targets, attitudes, and goals of psychiatrists treating patients with schizophrenia: key outcome drivers, role of quality of life, and place of long-acting antipsychotics

Discriminant Validity

Contact Info

Product

Resources

About